<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02750046</url>
  </required_header>
  <id_info>
    <org_study_id>SencondSoochowU</org_study_id>
    <nct_id>NCT02750046</nct_id>
  </id_info>
  <brief_title>Study of A Special Vessel Subtype in Bone Samples From Patients With Osteoporotic and Nonosteoporotic Fracture</brief_title>
  <official_title>Collection of Bone Specimens for Testing of A Special Vessel Subtype</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital of Soochow University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital of Soochow University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Collecting and storing bone samples from patients with osteoporotic and
      nonosteoporotic fracture to study a special vessel subtype in the laboratory may help surgeon
      learn more about the relationship between bone mineral density (BMD) and a special vessel
      subtype (type H vessel).

      PURPOSE: This research study is looking at changes of a special vessel subtype in bone
      samples from patients with osteoporotic and nonosteoporotic fracture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        1. Establish type H vessel in bone specimen in patients with hip fracture.

        2. Explore the correlation of BMD and type H vessel.

      OUTLINE:

        1. Collect human bone specimens from patients with Osteoporotic and Nonosteoporotic
           Fracture.

        2. Provide a repository for storage of tissue and make these specimens available for
           approved projects by laboratory-based investigators.

        3. Observe the type H vessel in bone slice by immunofluorescence staining.

        4. Collect clinical data on these patients including bone mineral density.

        5. Investigate the relationship between BMD and type H vessel.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The area of a special vessel subtype in human bone samples</measure>
    <time_frame>3 months</time_frame>
    <description>Bone samples were fixed in 4% PFA, decalcified, dehydrated, embedded and immunofluorescent staining for 3 months. Calculate the proportion of the special vessel of total vessel.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The value of bone mineral density</measure>
    <time_frame>1 week</time_frame>
    <description>Bone mineral density was measured by double energy X-ray absorptiometer (DXA) in a week before surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of of bone mineral density and area of a special vessel subtype in human bone</measure>
    <time_frame>2 months</time_frame>
    <description>Calculate correlation coefficient of BMD and type H vessel in human bone samples in 2 months.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Femoral Neck Fractures</condition>
  <arm_group>
    <arm_group_label>osteoporotic fractures</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with osteoporotic fractures, including femoral neck fracture and pertrochanteric fracture. Total hip arthroplasty or proximal femoral nails was needed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nonosteoporotic fractures</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patients with nonosteoporotic fractures, including femoral neck fracture and pertrochanteric fracture. Total hip arthroplasty or proximal femoral nails was needed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>total hip arthroplasty or proximal femoral nails</intervention_name>
    <description>Bone samples from Hip fracture were collected when total hip arthroplasty or proximal femoral nails was performed.</description>
    <arm_group_label>osteoporotic fractures</arm_group_label>
    <arm_group_label>nonosteoporotic fractures</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ages Eligible for Study: 65-75 Years

          2. Genders Eligible for Study: Woman

          3. Accepts Healthy Volunteers: NO

          4. Study Population: Female patients with hip fracture. -

        Exclusion Criteria:

          1. Malignancy or benign ovarian cysts

          2. Known chronic or systemic diseases

          3. Hormone therapy in the previous 3 months

          4. Bone metabolism and drug therapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Youjia Xu, PhD. M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Second Affiliated Hospital of Soochow University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Second Affiliated Hospital of Soochow University</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014 Mar 20;507(7492):323-328. doi: 10.1038/nature13145. Epub 2014 Mar 12. Erratum in: Nature. 2014 Sep 25;513(7519):574.</citation>
    <PMID>24646994</PMID>
  </results_reference>
  <results_reference>
    <citation>Xie H, Cui Z, Wang L, Xia Z, Hu Y, Xian L, Li C, Xie L, Crane J, Wan M, Zhen G, Bian Q, Yu B, Chang W, Qiu T, Pickarski M, Duong LT, Windle JJ, Luo X, Liao E, Cao X. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med. 2014 Nov;20(11):1270-8. doi: 10.1038/nm.3668. Epub 2014 Oct 5.</citation>
    <PMID>25282358</PMID>
  </results_reference>
  <results_reference>
    <citation>Ramasamy SK, Kusumbe AP, Wang L, Adams RH. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature. 2014 Mar 20;507(7492):376-380. doi: 10.1038/nature13146. Epub 2014 Mar 12.</citation>
    <PMID>24647000</PMID>
  </results_reference>
  <results_reference>
    <citation>Kusumbe AP, Adams RH. Osteoclast progenitors promote bone vascularization and osteogenesis. Nat Med. 2014 Nov;20(11):1238-40. doi: 10.1038/nm.3747.</citation>
    <PMID>25375923</PMID>
  </results_reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 24, 2016</study_first_submitted>
  <study_first_submitted_qc>April 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2016</study_first_posted>
  <last_update_submitted>April 20, 2016</last_update_submitted>
  <last_update_submitted_qc>April 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Femoral Neck Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

